Yves Agid

Active 1973–2022

294
Papers
77,220
Citations
150
h-index
293
i10-index

Citations

Citations per year for Yves Agid1932: 1 citations1967: 5 citations1973: 5 citations1974: 14 citations1975: 16 citations1976: 22 citations1977: 24 citations1978: 30 citations1979: 27 citations1980: 38 citations1981: 20 citations1982: 31 citations1983: 47 citations1984: 59 citations1985: 64 citations1986: 113 citations1987: 109 citations1988: 108 citations1989: 209 citations1990: 185 citations1991: 184 citations1992: 185 citations1993: 173 citations1994: 223 citations1995: 229 citations1996: 375 citations1997: 498 citations1998: 591 citations1999: 645 citations2000: 797 citations2001: 721 citations2002: 851 citations2003: 929 citations2004: 891 citations2005: 773 citations2006: 909 citations2007: 814 citations2008: 865 citations2009: 824 citations2010: 755 citations2011: 815 citations2012: 734 citations2013: 797 citations2014: 698 citations2015: 622 citations2016: 583 citations2017: 559 citations2018: 494 citations2019: 1,623 citations2020: 1,415 citations2021: 1,285 citations2022: 1,012 citations2023: 649 citations2024: 968 citations2025: 412 citations2026: 16 citations1933–1966: no citations, so these years are not shown1968–1972: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,344 citing papers, 27% of this breakdownUnited Kingdom: 2,463 citing papers, 9.1% of this breakdownGermany: 1,949 citing papers, 7.2% of this breakdownFrance: 1,851 citing papers, 6.8% of this breakdownItaly: 1,400 citing papers, 5.1% of this breakdownCanada: 1,333 citing papers, 4.9% of this breakdownChina: 1,200 citing papers, 4.4% of this breakdownSpain: 858 citing papers, 3.2% of this breakdownJapan: 813 citing papers, 3% of this breakdownAustralia: 748 citing papers, 2.7% of this breakdownNetherlands: 747 citing papers, 2.7% of this breakdownSwitzerland: 520 citing papers, 1.9% of this breakdown
0%27%Other 22%

Fields

  • Medicine56.4%
  • Neuroscience25.7%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Psychology3.2%
  • Nursing1.1%
  • Health Professions0.5%
  • Other2.9%

Topics

  • Parkinson's Disease Mechanisms and Treatments13.9%
  • Neurological disorders and treatments9.6%
  • Genetic Neurodegenerative Diseases4.3%
  • Alzheimer's disease research and treatments3.5%
  • Neuroscience and Neuropharmacology Research3%
  • Mitochondrial Function and Pathology2.2%
  • Other63.5%

Coauthors

All papers

Open in search
  1. Neurostimulation for Parkinson's Disease with Early Motor Complications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Damier, Sylvie Raoul, F. Sixel-Doering, D. Hellwig, Alireza Gharabaghi, Rejko Krüger, M. Pinsker, F. Amtage, João Marcos Gomes Regis, Tatiana Witjas, Stéphane Thobois, Patrick Mertens, M. Kloss, A. Hartmann, Wolfgang H. Oertel, Bart Post, Hans Speelman, Yves Agid, Carmen Schade‐Brittinger, Günther Deuschl - New England Journal of Medicine 2013 cited by 1,436

  2. The substantia nigra of the human brain

    Authors: , , , - Brain 1999 cited by 1,765

  3. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Drug Discovery 2012 cited by 1,297

  4. ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

    Authors: , , , , , , , , - Brain 1991 cited by 1,044

  5. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

    Authors: , , , , , , , , , , , , , , - Neurology 1996 cited by 2,516

  6. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease

    Authors: , , , , , , , , - Nature reviews. Neuroscience 2010 cited by 1,150

  7. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

    Authors: , , , , , , , - Annals of Neurology 1994 cited by 1,153

  8. Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Hardy, Nicholas Wood, Thomas Gasser, Alexandra Dürr, Jean‐François Deleuze, Mériem Tazir, A. Destée, Ebba Lohmann, Edor Kabashi, Andrew Singleton, Olga Corti, Alexis Brice, Suzanne Lesage, François Tison, Marie Vidailhet, Jean‐Christophe Corvol, Yves Agid, Mathieu Anheim, Anne-Marie Bonnet, Michel Borg, Emmanuel Broussolle, Philippe Damier, A. Destée, Alexandra Dürr, Franck Durif, Paul Krack, Stephan Klebe, Ebba Lohmann, María Martínez, Pierre Pollak, Olivier Rascol, Christine Tranchant, Marc Vérin, François Viallet, Alexis Brice, Suzanne Lesage, Elisa Majounie, François Tison, Marie Vidailhet, Jean‐Christophe Corvol, Michael A. Nalls, Dena G. Hernandez, J. Raphael Gibbs, Alexandra Dürr, Sampath Arepalli, Roger A. Barker, Yoav Ben‐Shlomo, Daniela Berg, Francesco Bettella, Kailash P. Bhatia, Rob M.A. de Bie, Alessandro Biffi, Bastiaan R. Bloem, Zoltán Bochdanovits, Michael von Bonin, Suzanne Lesage, François Tison, Marie Vidailhet, Jean‐Christophe Corvol, Yves Agid, Mathieu Anheim, Anne-Marie Bonnet, Michel Borg, Emmanuel Broussolle, Philippe Damier, A. Destée, Alexandra Dürr, Franck Durif, Paul Krack, Stephan Klebe and 123 more - The American Journal of Human Genetics 2016 cited by 447

  9. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

    Authors: , , , , , , - Journal of Neurochemistry 1989 cited by 1,148

  10. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

    Authors: , , - Nature 1988 cited by 1,292

  11. Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,426

  12. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

    Authors: , , , , , , , - Journal of Neurochemistry 1989 cited by 1,400

  13. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

    Authors: , , , , , , , , , - 1997 cited by 1,041

  14. Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease

    Authors: , , , , , , , , - The Lancet 2004 cited by 1,052

  15. Subthalamic Nucleus Stimulation in Severe Obsessive–Compulsive Disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alim‐Louis Benabid, Yves Agid, Paul Krack, Bruno Millet, Antoine Pélissolo - New England Journal of Medicine 2008 cited by 947

  16. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsaw

    Authors: , , , , , , , , , - BMJ 1999 cited by 947

  17. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 705

  18. Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Krack, Vélina Negovanska, Marie‐Laure Welter, Jean‐Christophe Corvol, Yves Agid, Soledad Navarro, Niklaus Meier, Andreas Hartmann, Helke Hesekamp, Philippe Cornu, Bettina Möller, Adelheid Nebel, Jan Raethjen, Karina Knudsen, Jens Volkmann, Daniela Falk, Steffen Paschen, Ingo G. Meister, Jens H. Kuhn, Kerstin Donner, Josef Kessler, Michael T. Barbe, Gereon Fink, Mohammad Maarouf, Andrea A. Kühn, Bianca Müller, Katharina Faust, Doreen Gruber, Gerd‐Helge Schneider, Éric Seigneuret, Pierre Pollak, Valérie Fraix, Andrea Kistner, Olivier Rascol, Christophe Arbus, Lola Danet, Patrick Chaynes, Stefan Jun Groiss, Christian Hartmann, Martin Südmeyer, Mahnaz Partowinia-Peters, Jan Vesper, Severine Ledily, Philippe Damier, Sylvie Raoul, Claudia Trenkwalder, Wenke Richter-Dreske, Tobias Wächter, Daniel Weiß, Alexandro Eusebio, Jean Philippe Azulay, Gustavo Polo, Serge Pinto, Johannes Levin, Stephanie Dornier, Fredy Pene, Delphine Hourton, Mathieu Quintin, Cécile Hoffart-Jourdain, Hélène Brocvielle, Kerstin Balthasar, Meryem Stein, Susanne Harnisch, Alexander Reuß, Behnaz Aminossadati, Christian Nasemann, Wolfgang H. Oertel, B. Bataille, Dieter Hellwig, Alireza Gharabaghi and 5 more - The Lancet Neurology 2018 cited by 169

  19. INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN

    Authors: , , , , , , - The Lancet 1987 cited by 967

  20. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain 2005 cited by 1,053

  21. Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2005 cited by 1,078

  22. Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia

    Authors: , , , , , , , , - New England Journal of Medicine 1996 cited by 1,075

  23. Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis

    Authors: , , , , - Journal of Neurochemistry 1991 cited by 535

  24. Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Massimo Scerrati, Marc Janssens, Anthony E. Lang - Movement Disorders 2010 cited by 460